1. Home
  2. ADCT vs MED Comparison

ADCT vs MED Comparison

Compare ADCT & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$1.27

Market Cap

136.1M

Sector

Health Care

ML Signal

HOLD

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$10.35

Market Cap

122.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADCT
MED
Founded
2011
1980
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
136.1M
122.8M
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
ADCT
MED
Price
$1.27
$10.35
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$7.75
$12.00
AVG Volume (30 Days)
1.5M
280.9K
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
30.86
N/A
EPS
N/A
N/A
Revenue
$81,357,000.00
$934,842,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$66.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.85
N/A
52 Week Low
$0.78
$9.22
52 Week High
$4.98
$15.37

Technical Indicators

Market Signals
Indicator
ADCT
MED
Relative Strength Index (RSI) 40.09 37.02
Support Level $0.78 $10.01
Resistance Level $1.44 $11.03
Average True Range (ATR) 0.11 0.35
MACD 0.08 -0.01
Stochastic Oscillator 60.67 20.37

Price Performance

Historical Comparison
ADCT
MED

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Share on Social Networks: